Spots Global Cancer Trial Database for A Study to Evaluate the Safety and Efficacy of CNTX-4975 in Subjects With Painful Intermetatarsal Neuroma (Morton's Neuroma)
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: A Study to Evaluate the Safety and Efficacy of CNTX-4975 in Subjects With Painful Intermetatarsal Neuroma (Morton's Neuroma)
Official Title: An Open-Label, Multiple-Dose Extension Study to Evaluate the Safety and Efficacy of CNTX-4975 in Subjects With Painful Intermetatarsal Neuroma (Morton's Neuroma)
Study ID: NCT02678793
Conditions
Interventions
Study Description
Brief Summary: Subjects who have completed study 4975-MN-202 will be eligible to receive open-label treatment with CNTX-4975 200 µg in study 4975-MN-203 if they meet the inclusion/exclusion criteria.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Arizona Research Center, Phoenix, Arizona, United States
NEA Baptist Clinic, Jonesboro, Arkansas, United States
TriWest Research Associates, LLC, El Cajon, California, United States
Chesapeake Research Group, Pasadena, Maryland, United States
Center for Advanced Medicine & Research, Saint Peters, Missouri, United States
University Orthopedics Center, Altoona, Pennsylvania, United States
University Orthopedics Center, State College, Pennsylvania, United States
Allcare Foot and Ankle Centre, Arlington, Texas, United States
Wasatch Clinical Research, Salt Lake City, Utah, United States
The Education & Research Foundation, Inc., Lynchburg, Virginia, United States
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
